Catalyst Wire Dossier Catalyst Wire Dossier

Mitoguazone dihydrochloride

mitoguazone dihydrochloride · Genzyme, a Sanofi Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mitoguazone dihydrochloride, covering 2020-12-19 to 2020-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma [Phase 2]

See pricing